The Kaohsiung journal of medical sciences
Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling.
Li-Jing Jiao, Jing Zhou, Jing Wang, Si-Nan Zhao, Zhan-Sheng Zhao, Qian Wang, Ya-Nan Xie, Wei Jiao
Published: 202510.1002/kjm2.70149
Abstract
Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogli…
Preview only. Read the full abstract at the source